EGFR-expressing effector T cells proliferate better and produce more IFN-γ and TNF-α in the presence of EGFR ligands produced by tumor cells in vitro and exerted stronger antitumor response delaying tumor growth in vivo. Here, IFNG is linked to neoplasm.